Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick E Hubbard

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Plos Computational Biology|April 12, 2014
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acidsSergio Ruiz-Carmona, Daniel Alvarez-Garcia, Nicolas Foloppe, et al.
Drug Discovery Today|May 9, 2018
When fragments link: a bibliometric perspective on the development of fragment-based drug discoveryAngelo K S Romasanta, Peter van der Sijde, Iina Hellsten, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structuresBrian Dymock, Xavier Barril, Mandy Beswick, et al.
Journal of the American Chemical Society|September 14, 2019
Water Networks Can Determine the Affinity of Ligand Binding to ProteinsJohn F Darby, Adam P Hopkins, Seishi Shimizu, et al.
Bioorganic & Medicinal Chemistry|May 6, 2014
Probing linker design in citric acid-ciprofloxacin conjugatesStephen J Milner, Anna M Snelling, Kevin G Kerr, et al.
Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.
Cell Reports|October 16, 2025
P-Rex1 limits the agonist-induced internalization of GPCRs independently of its Rac-GEF activityMartin J Baker, Elizabeth Hampson, Priota Islam, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.
Chemistry & Biology|June 26, 2004
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoformsLisa Wright, Xavier Barril, Brian Dymock, et al.
Chemmedchem|February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 InhibitorsSzabolcs Sipos, Barbara Balazs, Tamas Gati, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Plos Computational Biology|April 12, 2014
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acidsSergio Ruiz-Carmona, Daniel Alvarez-Garcia, Nicolas Foloppe, et al.
Drug Discovery Today|May 9, 2018
When fragments link: a bibliometric perspective on the development of fragment-based drug discoveryAngelo K S Romasanta, Peter van der Sijde, Iina Hellsten, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structuresBrian Dymock, Xavier Barril, Mandy Beswick, et al.
Journal of the American Chemical Society|September 14, 2019
Water Networks Can Determine the Affinity of Ligand Binding to ProteinsJohn F Darby, Adam P Hopkins, Seishi Shimizu, et al.
Bioorganic & Medicinal Chemistry|May 6, 2014
Probing linker design in citric acid-ciprofloxacin conjugatesStephen J Milner, Anna M Snelling, Kevin G Kerr, et al.
Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.
Cell Reports|October 16, 2025
P-Rex1 limits the agonist-induced internalization of GPCRs independently of its Rac-GEF activityMartin J Baker, Elizabeth Hampson, Priota Islam, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.
Chemistry & Biology|June 26, 2004
Structure-activity relationships in purine-based inhibitor binding to HSP90 isoformsLisa Wright, Xavier Barril, Brian Dymock, et al.
Chemmedchem|February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 InhibitorsSzabolcs Sipos, Barbara Balazs, Tamas Gati, et al.
Pageof 8